Adverse drug reaction due to concomitant vaccine administration of Covishield and Hepatitis-B in a patient with multidrug allergies
Abstract
Abstract: A 33-year-old male patient having multiple drug allergies but well tolerated to Hepatitis-B vaccine (vaccinated in April 2016) on receiving a second booster dose of Hepatitis-B vaccine (GeneVac-B) within 10 days of Covishield first dose immunization experienced a sharp rise in blood pressure, facial flushing, heaviness of head and eyes, dizziness, and palpitation accompanied with rashes in the right arm after 30 min of receiving the Hepatitis-B vaccine. Since no data is available on coadministration of other vaccines along with Covishield, serious investigations are commendable to deduce potential adverse events for universal acceptance.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Artificial Intelligence in Medicine: Cross-Sectional Study Among Medical Students on Application, Education, and Ethical Aspects
- Information quality of videos related to esophageal cancer on tiktok, kwai, and bilibili: a cross-sectional study
- The quality and reliability of short videos about hypertension on TikTok: a cross-sectional study
- Quality and reliability evaluation of pancreatic cancer-related video content on social short video platforms: a cross-sectional study
- Quality and reliability of pediatric pneumonia related short videos on mainstream platforms: cross-sectional study
- Association between metabolic score for insulin resistance (METS-IR) and hypertension: a cross-sectional study based on NHANES 2007–2018
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.